Prime Medicine, Inc.PRMENASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank17
3Y CAGR-9.2%
5Y CAGR-37.3%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
-9.2%/yr
Annual compound
5Y CAGR
-37.3%/yr
Recent acceleration
Percentile
P17
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
20254.27+88.9%
20242.26-62.7%
20236.06+6.1%
20225.71-7.0%
20216.14-86.0%
202043.96-95.9%
20191059.30-